Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mild Crohn’s Disease: Definition and Management
Jennifer Claytor, Pushkar Kumar, Ashwin N. Ananthakrishnan, et al.
Current Gastroenterology Reports (2023) Vol. 25, Iss. 3, pp. 45-51
Closed Access | Times Cited: 19

Showing 19 citing articles:

A Simple Endoscopic Score for Crohn's Disease (SES‐CD) ≥ 7 Predicts Disease Progression
Jellyana Peraza, Marco Emilio Kaper, A Bargas, et al.
Alimentary Pharmacology & Therapeutics (2025)
Closed Access | Times Cited: 2
Overcoming the challenges of overtreating and undertreating inflammatory bowel disease
María José Temido, Sailish Honap, Vipul Jairath, et al.
˜The œLancet. Gastroenterology & hepatology (2025)
Closed Access | Times Cited: 2
Colon-Targeted Hydrogel Microsphere System Encapsulating Oleic Acid–Emodin for Crohn’s Disease Treatment via Ferroptosis Inhibition
D. T. Yan, Yingqi Wei, Xiaona Ye, et al.
ACS Applied Materials & Interfaces (2025) Vol. 17, Iss. 9, pp. 13676-13689
Closed Access | Times Cited: 1
Fecal microbiota is associated with extraintestinal manifestations in inflammatory bowel disease
Sandra Hertz, Jacqueline Moltzau Anderson, Hans Linde Nielsen, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 4
Microbe-Derived Antioxidants Protect IPEC-1 Cells from H2O2-Induced Oxidative Stress, Inflammation and Tight Junction Protein Disruption via Activating the Nrf2 Pathway to Inhibit the ROS/NLRP3/IL-1β Signaling Pathway
Cheng Shen, Zhen Luo, Sheng Ma, et al.
Antioxidants (2024) Vol. 13, Iss. 5, pp. 533-533
Open Access | Times Cited: 4
Three-dimensional environment sensitizes pancreatic cancer cells to the anti-proliferative effect of budesonide by reprogramming energy metabolism
Eduardo Ibello, Federica Saracino, Donatella Delle Cave, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 4
Medical Management of Ulcerative Colitis and Crohn’s Disease—Strategies for Inducing and Maintaining Remission
Mohamed Tausif Siddiqui, Rhytha Kasiraj, Maliha Naseer
Surgical Clinics of North America (2025) Vol. 105, Iss. 2, pp. 435-454
Closed Access
The Dilemmas of Disclosing Crohn’s Disease at Work and the Factors Impacting the Decision
Νικόλαος Μάρκου, Doxa Papakonstantinou
Gastrointestinal Disorders (2025) Vol. 7, Iss. 1, pp. 18-18
Open Access
Genetic and environmental factors influencing Crohn’s disease
Ye-Hui Fan, Mingwei Wang, Yubo Gao, et al.
World Journal of Gastrointestinal Surgery (2025) Vol. 17, Iss. 3
Closed Access
Importance of Enteral Feeding: Enhancing Patient Care through Interventional Radiology
Abdifatah S Omar, Hyeonseon Kim, Michelle Mai, et al.
Seminars in Interventional Radiology (2025)
Closed Access
The Modulation of Cell Plasticity by Budesonide: Beyond the Metabolic and Anti-Inflammatory Actions of Glucocorticoids
Eduardo J. Patriarca, Cristina D’Aniello, Dario De Cesare, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 504-504
Open Access
Efficacy and safety of stem cell therapy for Crohn’s disease: a meta-analysis of randomized controlled trials
Yunfeng Qiu, Changfeng Li, Shihou Sheng
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Bile Acids as Signaling Molecules in Inflammatory Bowel Disease: Implications for Treatment Strategies
Yueyue Ma, Hong Yang, Xiaoming Wang, et al.
Journal of Ethnopharmacology (2024), pp. 118968-118968
Closed Access | Times Cited: 2
Management of Complications in Crohn’s Disease
Dylan Carroll, Sandy Kavalukas
Advances in Surgery (2024) Vol. 58, Iss. 1, pp. 19-34
Closed Access | Times Cited: 1
Flavonoid derivatives treat dextran sodium sulfate-induced experimental colitis in mice by inhibiting MAPK/NF-κB pathway activation
Cen Xiang, Quanyuan Qiu, Chunmei Zhang, et al.
European Journal of Medicinal Chemistry Reports (2024) Vol. 12, pp. 100196-100196
Open Access | Times Cited: 1
Experience of providing care to a family member with Crohn's disease and a temporary stoma: A qualitative study
Sicong Liu, Bowei Sun, Wenjie Tian, et al.
Heliyon (2023) Vol. 9, Iss. 10, pp. e21013-e21013
Open Access | Times Cited: 3
CROHN'S DISEASE AND GASTROINTESTINAL REPERCUSSIONS: A DETAILED STUDY OF COMORBIDITIES AND CLINICAL IMPLICATIONS
Júlia Cristina de Sousa Ramos, Eduardo Henrique Rezende, Murilo Dell Eugenio Costa Filho, et al.
Brazilian Journal of Implantology and Health Sciences (2024) Vol. 6, Iss. 4, pp. 90-103
Open Access
Cost Effectiveness of Sequencing Vedolizumab as First-Line Biologic in Ulcerative Colitis and Crohn's Disease in Canada: An Analysis Using Real-World Evidence from the EVOLVE Study
Aren Fischer, Stephen Mac, Erica Stivelman Freiman, et al.
PharmacoEconomics - Open (2024)
Open Access
Unveiling the therapeutic potential of quercetin and its metabolite (Q3OG) for targeting inflammatory pathways in Crohn's disease: A network pharmacology and molecular dynamics approach
Sarvesh Sabarathinam
Human Gene (2024), pp. 201372-201372
Closed Access
Page 1

Scroll to top